Maria Kózka1, Wioletta Skowron2, Iwona Bodys-Cupak3. 1. Jagiellonian University, Collegium Medicum, Faculty of Health Science, Institute of Nursing and Midwifery, Kraków, Poland. maria.kozka@uj.edu.pl. 2. Polonia Academia in Częstochowa, Faculty of Health Science, Częstochowa, Poland. 3. Jagiellonian University, Collegium Medicum, Faculty of Health Science, Institute of Nursing and Midwifery, Kraków, Poland. i.bodys-cupak@uj.edu.pl.
Abstract
INTRODUCTION: Ulcerative colitis is a chronic, inflammatory disease of the mucous membrane of the large intestine manifesting itself through diarrhoea with blood, mucous and pus. It progresses with periods of relapses and remissions. The treatment is a long-term process which should aim at improving the patient's clinical condition and quality of life, as well as minimising the disease-related anxiety and fears. OBJECTIVE: The aim of the study was recognition of the determinants of the level of anxiety and fears in a group of patients with ulcerative colitis. MATERIAL AND METHODS: The prospective study comprised 102 patients with diagnosed ulcerative colitis. The data were collected by means of the following tools: Clinical Disease Activity Index, Rating Form of IBD Patients Concerns (RFIPC), and a questionnaire by the authors. Statistical parametric and non-parametric tests were used to analyse the data, depending on the type of scale and nature of the variable distribution. RESULTS: Most of the patients (64%) were in the active phase of the disease. A high level of fear and anxiety occurred in 73% of the patients and concerned the impact of the disease, intimate life, complications and stigmatisation. The highest levels of fears and anxiety were observed in the field of complications and the impact of the disease on the patients' lives. CONCLUSIONS: The disease activity and high levels of anxiety and fears influenced the psychosocial functioning of the patients with ulcerative colitis.
INTRODUCTION:Ulcerative colitis is a chronic, inflammatory disease of the mucous membrane of the large intestine manifesting itself through diarrhoea with blood, mucous and pus. It progresses with periods of relapses and remissions. The treatment is a long-term process which should aim at improving the patient's clinical condition and quality of life, as well as minimising the disease-related anxiety and fears. OBJECTIVE: The aim of the study was recognition of the determinants of the level of anxiety and fears in a group of patients with ulcerative colitis. MATERIAL AND METHODS: The prospective study comprised 102 patients with diagnosed ulcerative colitis. The data were collected by means of the following tools: Clinical Disease Activity Index, Rating Form of IBDPatients Concerns (RFIPC), and a questionnaire by the authors. Statistical parametric and non-parametric tests were used to analyse the data, depending on the type of scale and nature of the variable distribution. RESULTS: Most of the patients (64%) were in the active phase of the disease. A high level of fear and anxiety occurred in 73% of the patients and concerned the impact of the disease, intimate life, complications and stigmatisation. The highest levels of fears and anxiety were observed in the field of complications and the impact of the disease on the patients' lives. CONCLUSIONS: The disease activity and high levels of anxiety and fears influenced the psychosocial functioning of the patients with ulcerative colitis.
Entities:
Keywords:
anxiety and fears; disease activity; ulcerative colitis
Authors: Awni Abu Sneineh; Sara Haj Ali; Ahmad Al-Masri; Amr Diab; Farah Aldweik; Mohammad Darweesh; Mohammad Qaisi; Osama Alshakhatreh; Tarek Tamimi; Yaser Rayyan; Radwan Banimustafa; Ibrahim Sablaban Journal: Sci Rep Date: 2022-05-10 Impact factor: 4.996
Authors: Alexander R Siebenhüner; Jean-Benoît Rossel; Philipp Schreiner; Matthias Butter; Thomas Greuter; Niklas Krupka; Sebastian B U Jordi; Luc Biedermann; Gerhard Rogler; Benjamin Misselwitz; Roland von Känel Journal: Therap Adv Gastroenterol Date: 2021-08-31 Impact factor: 4.409